The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
The federal government has begun using artificial intelligence to review whether certain treatments are necessary for ...
CMS announced the most recent round of awards Dec. 18, with hospitals receiving modest but targeted increases across primary care, behavioral health and other shortage specialties. The awards increase ...
Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...
The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...
CMS on Dec. 15 published 24 quality and efficiency measures under consideration for adoption in Medicare programs. HHS employs this pre-rulemaking process to decide on measures for Medicare programs ...
Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries with participating pharmaceutical manufacturers. Under ...
Ten Medicaid systems vendors have agreed to provide low or no cost services to states over the next two years. The Trump administration said the agreements would save $600 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results